LABU target price based on pitchfork analysisTwo pitchfork lines (one with dashed lines and one with sold lines) neatly matched their bottom lines. The price (approximately) reached that level 5 times. Further, the solid's middle red line matches pretty well the dashed pitchfork top lines. All these makes for a more confident prediction(s). The first is that the price will reach above 14 (the top dashed line), as marked. That would be above 75% increase from current price. At that point the price may or may not temporarily fall back after which I expect to continue up reaching above 22 (the marked top solid pitchfork line). That's over 175% profit.
I have been long on LABU since 6.47 (as posted elsewhere).
LABU
ABBV up;respecting wma50 despite LABU biotech 3x etf falling 10%ABBV is one of Warren Buffet’s holding in BRK.B. It has been respecting the weekly wma50 for a long time while holding an uptrend.
I think the sentiment has been too bearish & a shortterm rebound in the general market is due in the next few days.
Not trading advice.3
LABU 3X LEVERAGED BIOTECH ETF on support for LONGAMEX:LABU
LABU a 3x leveraged EFT in the biotechnology sector has diverse holdings.
My thesis is that biotechnology and healthcare are relatively unhinged from the broader general market.
On this 15 minute chart, consolidation at support is seen in July, Price then rapidly rose
into a triple top in mid-August followed by a descent into a double bottom at the support level.
This is a leveraged ETF with good volatility which can be traded.
The volume profile of July through mid-August sets a POC as 8,65. This is the best support level
within the zone. In the same fashion the volume profile of mid-August through the present sets
a POC at 12.45 which is the bottom of the resistance zone. The spread is approximately 40% upside
over perhaps two weeks of the expectant uptrend.
The zero-lag SMA / EMA oscillator is showing green at its most recent print with an uptrend noted.
I will take a trade in a call option with a strike 20 % higher than current price
given the potential immediate upside of 40%. I will select an expiration in 4-6 weeks and hope
for a 100-200% return.
LABU 3X Leverage BIOTECHNOLOGY a potential Recession playLABU a 3x leveraged EFT in the biotechnology sector has diverse holdings.
My thesis is that biotechnology and healthcare are relatively unhinged from the broader general market.
Here I chart LABU / QQQ ratio to determine relative strength.
On this weekly chart, the ratio and so relative strength are at more than a 52 week low.
The MACD indicator shows the MACD and signal line ascending and below the histogram.;
moreover the MACD in green is running above the signal line. This favors a trend reversal.
All in all, this seems to be a setup for a long swing trade or investment.
I will take a trade in a call option with a strike 50% higher than current price
as I see a potential for a large percentage gain for LABU. The diversity of the ETF
will serve to mitigate some of the risk. A stop loss will be 1% below current price
with an expectation of more than a 50 % return in the remainder of the calendar
year but far more in the case of the call option scenario
NVTA Breakout after EarningsNYSE:NVTA
a NASDAQ Penny Stock moving 10% today
after an earnings loss with a pullback and rebound.
Speculative but possibly with a good risk to reward
since it has already pulled back. Stochastic RSI
is low and all of this follows a long period
of consolidation. RElative up volume today
is 10-15X baseline showing good
accumulation.
Options for January 23 show reasonable volume
Put/Call ratio of 0.45 and volatility about 100%
LABU LEVERAGED BIOTECH ETFThis Daily Chart plots LABU to LABD ratios over time. LABU is 3X Leveraged ETF of a variety of biotechnology
stocks while LABD is the inverse.
By plotting the ratio of LABU to LABD, what can be found is the precise end of the LABU downtrend (LABD uptrend)
and reversal into LABU uptrend ( LABD downtrend).
In this case, the reversal occurred about June 17th while the SPY reached its current market bottom.
This type of analysis can be used to make trade decisions regarding a contrasting pair of stocks or forex pairs.
It makes the decisions more informed. IF going down to a 1H or 4H timeframe, the accuracies will be higher
and the pivots more frequent also making potential profits higher.
This can be used with other ETF inverses such as
GUST /DRIP
BOIL /KOLD
JDST / JNUG
YINN / YANG
SOXL/ SOXS
FAZ / FAS
TMF /TMV
By setting up all of these also with alerts such as ratio decreasing or ration increasing
a trader with very little time to trade and diversify and automate his/her trading
resulting in risk stratification and mitigation and economy of time.
Spotted potential cup and handle bottom on XBIIf the handle resistance is broken, it could have a nice rally up to at least $77.
Lots of wedge bottoms forming too which makes this set up even more bullish in my opinion.
However, the indicators look high on the 4 hour, so they might need to "recharge" before a breakout happens.
IBB Biotech reversal pattern after bounce from TL; low may be inIBB bounced from the green pandemic support zone last March but have came back down to retest this zone.
IBB has found support exactly on my GANN FAN line for several times before it breaks down & retested the violet downtrend line & bounced, making a reversal with a long hammer candle.
IBB may close today above my GANN FAN line support confirming reversal . Closing the next few days above 124 the pre-pandemic high would give added confidence to the bottom reversal pattern.
Next resistances are 127 & 136 to make a higher high.
Not trading advice
$XBI - Positive DivergenceThe SPDR BioTech ETF $XBI has been an underperforming for a long time. However, there's clues that could be changing. There's a nice positive divergence on the RSI. The down trend line was broken after several failed attempts. The stock is above the 50 day MA for the first time in over a year. Both the 20 SMA and the 50 SMA are curling upwards. RSI is positive. I like this long above the possible resistance area of $96.91.
The tripled levered bull equivalent $LABU looks just as good with even better volume.
I like the ETF long above $96.91. With a target up to the 200 SMA. of about $114.00
Under $96.91 and it's probably best to stay away.
Thanks for checking this out. Good luck to all.
LABU Bullish. LABUAs expected SNP Biotech sector is in the green and this has been reflected in our last update with every new and emerging biotech stock that we reviewed being convincingly bullish. We have and end to a zig zag formation here, this a corrective X Wave or a start of a new impulse ensures. We shall see which shall transpire in this instance.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
Is LABD looking to break out of this ascending triangle?As far as popular reversal patterns go, ascending triangles are no bottom of the barrel. Although I still am a new trader, I have been committed to the market for just over 1 year. With that said I have been watching LABD/LABU in proximity of market trends. When the overall market is bullish I trade LABU with success. When Market is bearish I trade LABD with success. My number #1 rule is follow the trend. That is why I am bullish on LABD. With the market making irrational highs despite COVID fears of a new variant, I have noted that LABD make this ascending triangle formation. So far it has held true. This could just be paranoid shizophrenia (I have an MD by the way), but my inner voice has been telling me to watch biotech for the market fall. My theory is that if and when the market falls LABD is going to get pumped like there is no tomorrow, similar to the VIX. But the good part is it is not as volatile as fear is. I can trade its inverse and watch the volume in both directions. So far it seems even, so i don't think any one knows what is coming next, except for maybe the FED. Unless LABU turns around I think LABD can go up to 40, if in fact there is a bubble burst on the horizon.